Amedeo Smart

Free Medical Literature Service



Ischemic Heart Disease

  Free Subscription

Articles published in
Thromb Haemost
    May 2018
  1. BATUCA JR, Amaral MC, Favas C, Justino GC, et al
    Antibodies against HDL Components in Ischaemic Stroke and Coronary Artery Disease.
    Thromb Haemost. 2018 May 3. doi: 10.1055/s-0038-1645857.
    >> Share

    April 2018
  2. PERTIWI KR, van der Wal AC, Pabittei DR, Mackaaij C, et al
    Neutrophil Extracellular Traps Participate in All Different Types of Thrombotic and Haemorrhagic Complications of Coronary Atherosclerosis.
    Thromb Haemost. 2018 Apr 19. doi: 10.1055/s-0038-1641749.
    >> Share

  3. GARAY A, Ariza-Sole A, Formiga F, Raposeiras-Roubin S, et al
    Prediction of Post-Discharge Bleeding in Elderly Patients with Acute Coronary Syndromes: Insights from the BleeMACS Registry.
    Thromb Haemost. 2018 Apr 3. doi: 10.1055/s-0038-1635259.
    >> Share

    March 2018
  4. CAMM AJ
    The Evolution of Antithrombotic Care in Cardiovascular Patients.
    Thromb Haemost. 2018 Mar 22. doi: 10.1055/s-0038-1626720.
    >> Share

  5. KANG J, Han JK, Ahn Y, Chae SC, et al
    Third-Generation P2Y12 Inhibitors in East Asian Acute Myocardial Infarction Patients: A Nationwide Prospective Multicentre Study.
    Thromb Haemost. 2018;118:591-600.
    >> Share

  6. ARIZA-SOLE A, Guerrero C, Formiga F, Aboal J, et al
    Global Geriatric Assessment and In-Hospital Bleeding Risk in Elderly Patients with Acute Coronary Syndromes: Insights from the LONGEVO-SCA Registry.
    Thromb Haemost. 2018;118:581-590.
    >> Share

    February 2018
  7. MJELVA OR, Svingen GFT, Pedersen EKR, Seifert R, et al
    Fibrinogen and Neopterin Is Associated with Future Myocardial Infarction and Total Mortality in Patients with Stable Coronary Artery Disease.
    Thromb Haemost. 2018 Feb 19. doi: 10.1055/s-0038-1629912.
    >> Share

  8. DE CARVALHO LP, Fong A, Troughton R, Yan BP, et al
    Prognostic Implications of Dual Platelet Reactivity Testing in Acute Coronary Syndrome.
    Thromb Haemost. 2018;118:415-426.
    >> Share

    January 2018
  9. VON KANEL R, Meister-Langraf RE, Schmid JP, Barth J, et al
    Low Self-rated Health Is Related to Blood Hypercoagulability in Patients Admitted with Acute Myocardial Infarction.
    Thromb Haemost. 2018;118:54-62.
    >> Share

  10. BURNLEY-HALL N, Abdul F, Androshchuk V, Morris K, et al
    Dietary Nitrate Supplementation Reduces Circulating Platelet-Derived Extracellular Vesicles in Coronary Artery Disease Patients on Clopidogrel Therapy: A Randomised, Double-Blind, Placebo-Controlled Study.
    Thromb Haemost. 2018;118:112-122.
    >> Share

  11. LOWE GDO
    Self-related Health and Blood Hypercoagulability: A Possible Mechanism for Cardiovascular Risk.
    Thromb Haemost. 2018;118:4-5.
    >> Share

    August 2017
  12. ZAFAR MU, Zafar M, Baber U, Smith DA, et al
    Antithrombotic potency of ticagrelor versus clopidogrel in type-2 diabetic patients with cardiovascular disease.
    Thromb Haemost. 2017;117.
    >> Share

  13. ANETSBERGER A, Blobner M, Haller B, Schmid S, et al
    Immature platelets as a novel biomarker for adverse cardiovascular events in patients after non-cardiac surgery.
    Thromb Haemost. 2017;117.
    >> Share

    July 2017
  14. HARADA Y, Michel J, Lohaus R, Mayer K, et al
    Validation of the DAPT score in patients randomized to 6 or 12 months clopidogrel after predominantly second-generation drug-eluting stents.
    Thromb Haemost. 2017;117.
    >> Share

  15. SILLER-MATULA J, Lang IM, Schoergenhofer C, Roest M, et al
    Interdependence between osteoprotegerin and active von Willebrand factor in long-term cardiovascular mortality prediction in patients undergoing percutaneous coronary intervention.
    Thromb Haemost. 2017;117.
    >> Share

    June 2017
  16. CUBEDO J, Blasco A, Padro T, Ramaiola I, et al
    Molecular signature of coronary stent thrombosis: oxidative stress and innate immunity cells.
    Thromb Haemost. 2017;117.
    >> Share

  17. TEN CATE H, Hackeng TM, Garcia de Frutos P
    Coagulation factor and protease pathways in thrombosis and cardiovascular disease.
    Thromb Haemost. 2017;117:1265-1271.
    >> Share

  18. SIBBING D, Angiolillo DJ, Huber K
    Antithrombotic therapy for acute coronary syndrome: Past, present and future.
    Thromb Haemost. 2017;117:1240-1248.
    >> Share

  19. PREISSNER KT, Herwald H
    Extracellular nucleic acids in immunity and cardiovascular responses: between alert and disease.
    Thromb Haemost. 2017;117:1272-1282.
    >> Share

    April 2017
  20. CHRISTERSSON C, Thulin A, Siegbahn A
    Microparticles during long-term follow-up after acute myocardial infarction. Association to atherosclerotic burden and risk of cardiovascular events.
    Thromb Haemost. 2017 Apr 20. doi: 10.1160/TH16-11-0837.
    >> Share

    March 2017
  21. CAMPO G, Vieceli Dalla Sega F, Pavasini R, Aquila G, et al
    Biological effects of ticagrelor over clopidogrel in patients with stable coronary artery disease and chronic obstructive pulmonary disease.
    Thromb Haemost. 2017 Mar 23. doi: 10.1160/TH16-12-0973.
    >> Share

  22. THOMAS MR, Angiolillo DJ, Bonaca MP, Ajjan RA, et al
    Consistent platelet inhibition with ticagrelor 60 mg twice-daily following myocardial infarction regardless of diabetes status.
    Thromb Haemost. 2017 Mar 16. doi: 10.1160/TH16-09-0703.
    >> Share

  23. TARANCON-DIEZ L, De Pablo-Bernal RS, Alvarez-Rios AI, Rosado-Sanchez I, et al
    CCR5+ CD8 T-cell levels and monocyte activation precede the onset of acute coronary syndrome in HIV-infected patients on antiretroviral therapy.
    Thromb Haemost. 2017 Mar 9. doi: 10.1160/TH16-11-0867.
    >> Share

    February 2017

  24. Erratum to Rutten et al. "Platelet density per monocyte predicts adverse events in patients after percutaneous coronary intervention" (Thromb Haemost 2016; 115: 353-360).
    Thromb Haemost. 2017;117:641.
    >> Share

  25. ZEYMER U, Hohlfeld T, Vom Dahl J, Erbel R, et al
    Prospective, randomised trial of the time dependent antiplatelet effects of 500 mg and 250 mg acetylsalicylic acid i. v. and 300 mg p. o. in ACS (ACUTE).
    Thromb Haemost. 2017;117:625-635.
    >> Share

  26. CHRISTOPOULOS C, Farag M, Sullivan K, Wellsted D, et al
    Impaired thrombolytic status predicts adverse cardiac events in patients undergoing primary percutaneous coronary intervention.
    Thromb Haemost. 2017;117:457-470.
    >> Share

  27. BIANCARI F, Brascia D, Onorati F, Reichart D, et al
    Prediction of severe bleeding after coronary surgery: the WILL-BLEED Risk Score.
    Thromb Haemost. 2017;117:445-456.
    >> Share

  28. URBANSKI K, Ludew D, Filip G, Filip M, et al
    CD14+CD16++ "nonclassical" monocytes are associated with endothelial dysfunction in patients with coronary artery disease.
    Thromb Haemost. 2017 Feb 23. doi: 10.1160/TH16-08-0614.
    >> Share

  29. ALLAN V, Honarbakhsh S, Casas JP, Wallace J, et al
    Are cardiovascular risk factors also associated with the incidence of atrial fibrillation? A systematic review and field synopsis of 23 factors in 32 population based cohorts of 20 million participants.
    Thromb Haemost. 2017 Feb 23. doi: 10.1160/TH16-11-0825.
    >> Share

  30. FREYNHOFER MK, Iliev L, Bruno V, Rohla M, et al
    Platelet turnover predicts outcome after coronary intervention.
    Thromb Haemost. 2017 Feb 23. doi: 10.1160/TH16-10-0785.
    >> Share

  31. NIEZGODA P, Sikora J, Baranska M, Sikora A, et al
    Crushed sublingual versus oral ticagrelor administration strategies in patients with unstable angina. A pharmacokinetic/pharmacodynamic study.
    Thromb Haemost. 2017 Feb 16. doi: 10.1160/TH16-08-0670.
    >> Share

  32. PARK Y, Tantry US, Koh JS, Ahn JH, et al
    Novel role of platelet reactivity in adverse left ventricular remodelling after ST-segment elevation myocardial infarction: The REMODELING Trial.
    Thromb Haemost. 2017 Feb 2. doi: 10.1160/TH16-10-0744.
    >> Share

  33. ASHER E, Frydman S, Katz M, Regev E, et al
    Chewing versus Swallowing Ticagrelor to Accelerate Platelet Inhibitionin Acute Coronary Syndrome - the CHEERS study. For The PLATIS (Platelets and Thrombosis in Sheba) Study Group.
    Thromb Haemost. 2017 Feb 2. doi: 10.1160/TH16-09-0728.
    >> Share

    January 2017
  34. CHATTERJEE M, Behrendt A, Schmid M, Beck S, et al
    Platelets as a novel source of Gremlin-1: Implications for thromboinflammation.
    Thromb Haemost. 2017;117:311-324.
    >> Share

    December 2016
  35. ZAKAI NA, McClure LA, Judd SE, Kissela B, et al
    D-dimer and the Risk of Stroke and Coronary Heart Disease. The REasons for Geographic and Racial Differences in Stroke (REGARDS) Study.
    Thromb Haemost. 2016 Dec 22. doi: 10.1160/TH16-07-0519.
    >> Share

  36. GAO J, Ma X, Zhang Y, Guo M, et al
    The role of microRNAs in prethrombotic status associated with coronary artery disease.
    Thromb Haemost. 2016 Dec 22. doi: 10.1160/TH16-07-0503.
    >> Share

    November 2016
  37. SCHOOLING CM, Zhong Y
    Plasma levels of the anti-coagulation protein C and the risk of ischaemic heart disease. A Mendelian randomisation study.
    Thromb Haemost. 2016.
    >> Share

  38. CHATTERJEE S, Weinberg I, Yeh RW, Chakraborty A, et al
    Risk factors for intracranial haemorrhage in patients with pulmonary embolism treated with thrombolytic therapy Development of the PE-CH Score.
    Thromb Haemost. 2016.
    >> Share

  39. KREUTZ RP, Schmeisser G, Maatman B, Schaffter A, et al
    Fibrin clot strength measured by thrombelastography and outcomes after percutaneous coronary intervention.
    Thromb Haemost. 2016.
    >> Share

    October 2016
  40. POURDJABBAR A, Hibbert B, Chong AY, Le May MR, et al
    A randomised study for optimising crossover from ticagrelor to clopidogrel in patients with acute coronary syndrome. The CAPITAL OPTI-CROSS Study.
    Thromb Haemost. 2016;117.
    >> Share

  41. FLIERL U, Zauner F, Sieweke JT, Berliner C, et al
    Efficacy of prasugrel administration immediately after percutaneous coronary intervention in ST-elevation myocardial infarction.
    Thromb Haemost. 2016;117.
    >> Share

    September 2016
  42. SIBBING D, Aradi D, Jacobshagen C, Gross L, et al
    A randomised trial on platelet function-guided de-escalation of antiplatelet treatment in ACS patients undergoing PCI. Rationale and design of the Testing Responsiveness to Platelet Inhibition on chronic Antiplatelet Treatment for Acute Coronary Syndr
    Thromb Haemost. 2016;117.
    >> Share

  43. DARWICHE W, Bejan-Angoulvant T, Angoulvant D, Babuty D, et al
    Risk of myocardial infarction and death in patients with atrial fibrillation treated with dabigatran or vitamin K antagonists. Meta-analysis of observational analyses.
    Thromb Haemost. 2016;116.
    >> Share

    July 2016
  44. WEBER C, Shantsila E, Hristov M, Caligiuri G, et al
    Role and analysis of monocyte subsets in cardiovascular disease. Joint consensus document of the European Society of Cardiology (ESC) Working Groups "Atherosclerosis & Vascular Biology" and "Thrombosis".
    Thromb Haemost. 2016;116.
    >> Share

  45. ANTIOCHOS P, Marques-Vidal P, Virzi J, Pagano S, et al
    Association between anti-apolipoprotein A-1 antibodies and cardiovascular disease in the general population. Results from the CoLaus study.
    Thromb Haemost. 2016;116.
    >> Share

    May 2016
  46. SANTILLI F, Marchisio M, Lanuti P, Boccatonda A, et al
    Microparticles as new markers of cardiovascular risk in diabetes and beyond.
    Thromb Haemost. 2016;116.
    >> Share

    March 2016
  47. WHITE SJ, Newby AC, Johnson TW
    Endothelial erosion of plaques as a substrate for coronary thrombosis.
    Thromb Haemost. 2016;115:509-19.
    >> Share

  48. MORBIDUCCI U, Kok AM, Kwak BR, Stone PH, et al
    Atherosclerosis at arterial bifurcations: evidence for the role of haemodynamics and geometry.
    Thromb Haemost. 2016;115:484-92.
    >> Share

    January 2016
  49. KIM JS, Han DC, Jeong YH, Park DW, et al
    Antiplatelet effect of ticagrelor compared to tirofiban in non-ST-segment elevation ACS patients undergoing PCI. The result of the TE-CLOT trial.
    Thromb Haemost. 2016;115:213-21.
    >> Share

  50. POHL J, Hendgen-Cotta UB, Rammos C, Luedike P, et al
    Targeted intracellular accumulation of macrophage migration inhibitory factor in the reperfused heart mediates cardioprotection.
    Thromb Haemost. 2016;115:200-12.
    >> Share

  51. HERTLE E, Arts IC, van der Kallen CJ, Feskens EJ, et al
    The alternative complement pathway is longitudinally associated with adverse cardiovascular outcomes. The CODAM study.
    Thromb Haemost. 2016;115:446-57.
    >> Share

  52. ASHER E, Fefer P, Sabbag A, Herscovici R, et al
    Prior chronic clopidogrel therapy is associated with increased adverse events and early stent thrombosis.
    Thromb Haemost. 2016;115:433-8.
    >> Share

  53. VERGALLO R, Aguirre AD, Abtahian F, Minami Y, et al
    Recurrent myocardial infarctions and premature coronary atherosclerosis in a 23-year-old man with antiphospholipid syndrome.
    Thromb Haemost. 2016;115:237-9.
    >> Share

  54. COLLET JP, Kerneis M, Hulot JS, O'Connor SA, et al
    Point-of-care genetic profiling and/or platelet function testing in acute coronary syndrome.
    Thromb Haemost. 2016;115:382-91.
    >> Share

  55. RUTTEN B, Roest M, McClellan EA, Sels JW, et al
    Platelet density per monocyte predicts adverse events in patients after percutaneous coronary intervention.
    Thromb Haemost. 2016;115:353-60.
    >> Share

Free Medical Abstracts
Privacy Policy

© Amedeo 1997-2016